Filippo Sean Giorgi Selected Research

Alzheimer Disease (Alzheimer's Disease)

1/2023	Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases.
1/2021	α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
10/2020	β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.
9/2019	Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
1/2018	Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.
10/2017	A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting.
3/2017	Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filippo Sean Giorgi Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 03/2017
7	Epilepsy (Aura) 01/2022 - 11/2014
6	Seizures (Absence Seizure) 04/2023 - 09/2007
4	Dementia (Dementias) 01/2023 - 10/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2019
4	Partial Epilepsies (Epilepsy, Partial) 12/2021 - 01/2015
4	Neuroinflammatory Diseases 01/2021 - 11/2019
3	Cognitive Dysfunction 01/2023 - 09/2007
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2023 - 01/2022
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2009
2	Juvenile Myoclonic Epilepsy 01/2021 - 11/2019
2	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 10/2017
1	Orthostatic Hypotension (Postural Hypotension) 11/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Movement Disorders (Movement Disorder) 10/2021
1	Lewy Body Disease (Lewy Body Dementia) 01/2021
1	Neoplasms (Cancer) 01/2020
1	Carcinogenesis 01/2020
1	Epileptic Syndromes 11/2019
1	Generalized Epilepsy 11/2019
1	Gliosis 11/2019
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2019
1	Catatonia 01/2018
1	Hemorrhage 01/2018
1	Infections 09/2017
1	Communicable Diseases (Infectious Diseases) 09/2017
1	Phenylketonurias (Phenylketonuria) 01/2014
1	Drug Resistant Epilepsy 08/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2009
6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 01/2015
6	Biomarkers (Surrogate Marker)IBA 11/2020 - 11/2014
4	Amyloid (Amyloid Fibrils)IBA 01/2023 - 09/2019
4	brivaracetamIBA 01/2022 - 09/2017
3	EnzymesIBA 01/2023 - 10/2020
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 09/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 11/2020
2	BicucullineIBA 01/2023 - 11/2014
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 06/2015
2	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 09/2017
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 09/2017
2	SynucleinsIBA 01/2021 - 09/2019
2	tau Proteins (tau Protein)IBA 01/2020 - 10/2017
1	hydroxide ionIBA 11/2023
1	Kainic Acid (Kainate)IBA 04/2023
1	Pentylenetetrazole (Metrazol)IBA 04/2023
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023
1	NeuregulinsIBA 01/2023
1	AMPA Receptors (AMPA Receptor)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 10/2021
1	ImmunosorbentsIBA 01/2021
1	CytokinesIBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	LigandsIBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	ProgranulinsIBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2019
1	Immunoglobulin E (IgE)IBA 11/2019
1	InterleukinsIBA 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019
1	AntioxidantsIBA 02/2018
1	Dabigatran FDA Link 01/2018
1	LithiumIBA 01/2018
1	RivaroxabanIBA 01/2018
1	apixabanIBA 01/2018
1	edoxabanIBA 01/2018
1	AnticoagulantsIBA 01/2018
1	Amyloid beta-PeptidesIBA 10/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 09/2017
1	Pregabalin (Lyrica)FDA Link 09/2017
1	perampanelIBA 09/2017
1	remacemideIBA 09/2017
1	Tiagabine (Gabitril)FDA Link 09/2017
1	Topiramate (Topamax)FDA LinkGeneric 09/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 09/2017
1	rufinamide FDA Link 09/2017
1	Lacosamide FDA Link 09/2017
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2017
1	ezogabine (retigabine)IBA 09/2017
1	Thyroid HormonesIBA 03/2017
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2014
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2014
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 09/2007

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2020
2	Precision Medicine 01/2023 - 01/2018
1	Chemoradiotherapy 01/2022
1	Vagus Nerve Stimulation 08/2003